{"entity":{"id":"modified-rna-nucleosides","kind":"term","name":"Modified nucleosides in messenger RNA","aka":["modified mRNA nucleosides","nucleoside-modified mRNA"],"tldr":"Chemical changes to RNA building blocks can alter how a message is sensed and translated. The effect depends on the RNA and the system in which it is tested.","summary":"Primary experiments found that selected nucleoside modifications changed RNA-triggered innate immune activation. Later work showed that purification of modified transcripts also affected inflammatory responses and protein expression. Modification and removal of contaminants are therefore distinct design and manufacturing questions. Results from those experimental systems do not establish that one modification is best for every cancer vaccine, delivery platform or intended immune response.\n\nIn cell lines and mice, N1-methylpseudouridine, alone or with 5-methylcytidine, gave higher reporter expression than pseudouridine-based mRNA, up to about 44-fold for double-modified mRNA and about 13-fold for single-modified mRNA as the abstract reports (cell lines and mice respectively), with less innate immunogenicity and better cell viability in vitro (Andries and colleagues). Separately, N1-methylpseudouridine caused +1 ribosomal frameshifting in vitro at slippery sequences, cellular immunity to +1 products was found in mice and humans after vaccination with BNT162b2 vaccine mRNA, and synonymous changes at those sequences reduced frameshifted products; the authors note that no adverse outcomes from mistranslation of the SARS-CoV-2 vaccines have been reported (Mulroney and colleagues). More reporter signal with less cytokine in one matched comparison does not show a stronger antigen-specific T-cell response: unmodified mRNAs were translated better after purification yet still induced high cytokine secretion, and purified modified mRNA was translated 10 to 1000-fold more in primary cells (Karikó and colleagues, 2011), so sensing, expression and T-cell readouts each need their own evidence.","asOf":"2026-11-09","links":[{"label":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.","url":"https://doi.org/10.1016/j.immuni.2005.06.008"},{"label":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.","url":"https://doi.org/10.1093/nar/gkr695"},{"label":"N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.","url":"https://doi.org/10.1016/j.jconrel.2015.08.051"},{"label":"N<sup>1</sup>-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.","url":"https://doi.org/10.1038/s41586-023-06800-3"},{"label":"OpenStax Organic Chemistry 28.1: nucleosides and nucleotides","url":"https://openstax.org/books/organic-chemistry/pages/28-1-nucleotides-and-nucleic-acids"}],"tags":[],"related":["dsrna-impurities","mrna-construct-anatomy","mrna-lnp-manufacturing"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["A nucleoside combines a base with a sugar; a nucleotide also carries phosphate. Modified RNA building blocks change chemistry separately from the intended sequence and from contaminating byproducts. Characterise chemistry and identity, impurities, protein identity and quantity, and innate-sensing readouts under matched sequence, amount, cap, UTR, purity and formulation conditions. A translation or cytokine result cannot establish every later immune or clinical outcome.","Karikó's 2005 experiments compared human TLR systems and dendritic-cell readouts under selected nucleoside modifications. In the 2011 study, modified transcripts still contained activating contaminants including double-stranded RNA, and purification changed innate activation and translation. A change in building-block chemistry is therefore separate from removal of byproducts."],"category":"Genomics & genetics"},"route":"/terms/modified-rna-nucleosides/","neighbours":{"term":[{"id":"dsrna-impurities","kind":"term","name":"Double-stranded RNA impurities","route":"/terms/dsrna-impurities/"},{"id":"immune-product-evidence","kind":"term","name":"Immune measurements and product evidence","route":"/terms/immune-product-evidence/"},{"id":"mrna-construct-anatomy","kind":"term","name":"Messenger RNA construct anatomy","route":"/terms/mrna-construct-anatomy/"}],"technology":[{"id":"mrna-lnp-manufacturing","kind":"technology","name":"mRNA and lipid nanoparticle manufacturing","route":"/technologies/mrna-lnp-manufacturing/"}]}}